Publication Information

{'id': 'https://openalex.org/W2113031878', 'doi': None, 'title': 'Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.', 'display_name': 'Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.', 'publication_year': 2003, 'publication_date': '2003-01-01', 'ids': {'openalex': 'https://openalex.org/W2113031878', 'mag': '2113031878', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12517791'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12517791', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5091332840', 'display_name': 'Takahito Hara', 'orcid': 'https://orcid.org/0000-0002-9941-9041'}, 'institutions': [{'id': 'https://openalex.org/I44892455', 'display_name': 'Takeda (Japan)', 'ror': 'https://ror.org/04hjbmv12', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I44892455']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Takahito Hara', 'raw_affiliation_strings': ['Pharmaceutical Research Laboratories, Takeda Chemical Industries, Ltd., Osaka 532-8686, Japan. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Pharmaceutical Research Laboratories, Takeda Chemical Industries, Ltd., Osaka 532-8686, Japan. [email protected]', 'institution_ids': ['https://openalex.org/I44892455']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052112864', 'display_name': 'Jun‐ichi Miyazaki', 'orcid': 'https://orcid.org/0000-0003-2475-589X'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jun-ichi Miyazaki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044801477', 'display_name': 'Hideo Araki', 'orcid': 'https://orcid.org/0000-0001-7116-6102'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hideo Araki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113598620', 'display_name': 'Masuo Yamaoka', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masuo Yamaoka', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090477990', 'display_name': 'Naoyuki Kanzaki', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Naoyuki Kanzaki', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075211314', 'display_name': 'Masami Kusaka', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masami Kusaka', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5020538210', 'display_name': 'Masaomi Miyamoto', 'orcid': 'https://orcid.org/0000-0003-4496-2685'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masaomi Miyamoto', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 15.852, 'has_fulltext': False, 'cited_by_count': 424, 'citation_normalized_percentile': {'value': 0.999942, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '63', 'issue': '1', 'first_page': '149', 'last_page': '53'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.997, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.997, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9905, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9632, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bicalutamide', 'display_name': 'Bicalutamide', 'score': 0.9540177}], 'concepts': [{'id': 'https://openalex.org/C2780962315', 'wikidata': 'https://www.wikidata.org/wiki/Q1988832', 'display_name': 'Bicalutamide', 'level': 5, 'score': 0.9540177}, {'id': 'https://openalex.org/C2779723316', 'wikidata': 'https://www.wikidata.org/wiki/Q6459234', 'display_name': 'LNCaP', 'level': 4, 'score': 0.90579045}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.7374948}, {'id': 'https://openalex.org/C2779322244', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogen', 'level': 4, 'score': 0.71610075}, {'id': 'https://openalex.org/C2777911890', 'wikidata': 'https://www.wikidata.org/wiki/Q62614', 'display_name': 'Androgen', 'level': 3, 'score': 0.5391676}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.50102663}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.49387652}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.44376966}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.43300557}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.40909377}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3802563}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.27462977}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.11143476}, {'id': 'https://openalex.org/C71315377', 'wikidata': 'https://www.wikidata.org/wiki/Q11364', 'display_name': 'Hormone', 'level': 2, 'score': 0.09851605}], 'mesh': [{'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D016297', 'descriptor_name': 'Mutagenesis, Site-Directed', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D013375', 'descriptor_name': 'Substance Withdrawal Syndrome', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': True}, {'descriptor_ui': 'D019943', 'descriptor_name': 'Amino Acid Substitution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000813', 'descriptor_name': 'Anilides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017931', 'descriptor_name': 'DNA Primers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018076', 'descriptor_name': 'DNA, Complementary', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018076', 'descriptor_name': 'DNA, Complementary', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011471', 'descriptor_name': 'Prostatic Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D011944', 'descriptor_name': 'Receptors, Androgen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020133', 'descriptor_name': 'Reverse Transcriptase Polymerase Chain Reaction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013375', 'descriptor_name': 'Substance Withdrawal Syndrome', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': False}, {'descriptor_ui': 'D013375', 'descriptor_name': 'Substance Withdrawal Syndrome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014105', 'descriptor_name': 'Tosyl Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014158', 'descriptor_name': 'Transcription, Genetic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014183', 'descriptor_name': 'Transplantation, Heterologous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014407', 'descriptor_name': 'Tumor Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12517791', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.83, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 17, 'referenced_works': ['https://openalex.org/W1816722347', 'https://openalex.org/W1999614615', 'https://openalex.org/W2009402948', 'https://openalex.org/W2033507378', 'https://openalex.org/W2034424013', 'https://openalex.org/W2039253501', 'https://openalex.org/W2057477877', 'https://openalex.org/W2060559284', 'https://openalex.org/W2061686178', 'https://openalex.org/W2066570340', 'https://openalex.org/W2095873383', 'https://openalex.org/W2165611177', 'https://openalex.org/W2166771233', 'https://openalex.org/W2166912270', 'https://openalex.org/W2168011358', 'https://openalex.org/W2340799873', 'https://openalex.org/W2766162865'], 'related_works': ['https://openalex.org/W2741925895', 'https://openalex.org/W2523942339', 'https://openalex.org/W2334177911', 'https://openalex.org/W2301143707', 'https://openalex.org/W2145777186', 'https://openalex.org/W2090356696', 'https://openalex.org/W2077735476', 'https://openalex.org/W2070517005', 'https://openalex.org/W1969187935', 'https://openalex.org/W1530978709'], 'abstract_inverted_index': {'Most': [0], 'prostate': [1], 'cancers': [2], '(PCs)': [3], 'become': [4, 70], 'resistant': [5], 'to': [6, 124, 141, 187, 196, 249, 260, 271], 'combined': [7, 127], 'androgen': [8, 63, 128], 'blockade': [9, 129], 'therapy': [10, 299], 'with': [11, 122, 305], 'surgical': [12], 'or': [13, 191], 'medical': [14], 'castration': [15], 'and': [16, 100, 153, 164, 216, 289], 'antiandrogens': [17], 'after': [18, 27, 143], 'several': [19], 'years.': [20], 'Some': [21], 'of': [22, 29, 40, 48, 51, 57, 62, 95, 146, 168, 245, 286], 'these': [23, 229], 'refractory': [24, 301], 'PCs': [25], 'regress': [26], 'discontinuation': [28], 'antiandrogen': [30], 'administration': [31], '[antiandrogen': [32], 'withdrawal': [33], 'syndrome': [34], '(AWS)].': [35], 'Although': [36], 'the': [37, 41, 49, 58, 71, 93, 96, 126, 173, 201, 237, 277, 287], 'molecular': [38], 'mechanisms': [39, 94], 'AWS': [42, 288], 'are': [43], 'not': [44, 77, 134], 'fully': [45], 'understood': [46], 'because': [47], 'lack': [50], 'suitable': [52], 'experimental': [53], 'models,': [54], 'one': [55, 283], 'hypothesis': [56, 278], 'mechanism': [59, 285], 'is': [60, 282], 'mutation': [61, 181, 270, 281], 'receptor': [64], '(AR).': [65], 'However,': [66], 'bicalutamide,': [67, 250], 'which': [68, 107], 'has': [69], 'most': [72], 'prevalent': [73], 'pure': [74], 'antiandrogen,': [75, 222], 'does': [76], 'work': [78], 'as': [79, 210, 225, 263, 296], 'an': [80, 211, 226, 264], 'agonist': [81, 212, 266], 'for': [82, 213, 228, 236, 300], 'any': [83], 'mutant': [84, 218, 230], 'AR': [85, 169, 174, 265, 269, 280], 'detected': [86], 'thus': [87], 'far': [88], 'in': [89, 110, 119, 162, 165, 175, 182, 192, 200, 246], 'PC.': [90], 'To': [91], 'elucidate': [92], 'AWS,': [97], 'we': [98, 234], 'established': [99], 'characterized': [101], 'novel': [102, 180], 'LNCaP': [103], 'cell': [104, 151], 'sublines,': [105], 'LNCaP-cxDs,': [106], 'were': [108], 'generated': [109], 'vitro': [111, 163, 247], 'by': [112], 'culturing': [113], 'androgen-dependent': [114], 'LNCaP-FGC': [115, 131, 251], 'human': [116], 'PC': [117, 302], 'cells': [118, 132, 160, 177], 'androgen-depleted': [120], 'medium': [121], 'bicalutamide': [123, 208, 262], 'mimic': [125], 'therapy.': [130], 'did': [133], 'grow': [135, 142], 'at': [136], 'first,': [137], 'but': [138], 'they': [139], 'started': [140], '6-13': [144, 243], 'weeks': [145, 244], 'culture.': [147], 'Bicalutamide': [148], 'stimulated': [149], 'LNCaP-cxD': [150, 159, 176], 'growth': [152, 254], 'increased': [154], 'prostate-specific': [155], 'antigen': [156], 'secretion': [157], 'from': [158], 'both': [161, 214], 'vivo.': [166], 'Sequencing': [167], 'transcripts': [170], 'revealed': [171], 'that': [172, 207, 240, 279, 291], 'harbors': [178], 'a': [179, 297], 'codon': [183, 193], '741,': [184, 194], 'TGG': [185, 195], '(tryptophan)': [186], 'TGT': [188], '(cysteine;': [189], 'W741C),': [190], 'TTG': [197], '(leucine;': [198], 'W741L),': [199], 'ligand-binding': [202], 'domain.': [203], 'Transactivation': [204], 'assays': [205], 'showed': [206], 'worked': [209, 224], 'W741C': [215], 'W741L': [217], 'ARs.': [219, 231], 'Importantly,': [220], 'another': [221], 'hydroxyflutamide,': [223], 'antagonist': [227], 'In': [232], 'summary,': [233], 'demonstrate': [235], 'first': [238], 'time': [239], 'within': [241], 'only': [242], 'exposure': [248], 'cells,': [252], 'whose': [253], 'had': [255], 'initially': [256], 'been': [257], 'suppressed,': [258], 'came': [259], 'use': [261], 'via': [267], 'W741': [268], 'survive.': [272], 'Our': [273], 'data': [274], 'strongly': [275], 'support': [276], 'possible': [284], 'suggest': [290], 'flutamide': [292], 'might': [293], 'be': [294], 'effective': [295], 'second-line': [298], 'previously': [303], 'treated': [304], 'bicalutamide.': [306]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2113031878', 'counts_by_year': [{'year': 2024, 'cited_by_count': 6}, {'year': 2023, 'cited_by_count': 9}, {'year': 2022, 'cited_by_count': 13}, {'year': 2021, 'cited_by_count': 24}, {'year': 2020, 'cited_by_count': 13}, {'year': 2019, 'cited_by_count': 13}, {'year': 2018, 'cited_by_count': 19}, {'year': 2017, 'cited_by_count': 23}, {'year': 2016, 'cited_by_count': 23}, {'year': 2015, 'cited_by_count': 29}, {'year': 2014, 'cited_by_count': 27}, {'year': 2013, 'cited_by_count': 29}, {'year': 2012, 'cited_by_count': 16}], 'updated_date': '2024-12-15T13:26:42.896437', 'created_date': '2016-06-24'}